Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection (Q63369615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Mycobacterium bovis

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

E Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J A Triccas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A T Kamath

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W J Britton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

482-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737066%20AND%20SRC:MED&resulttype=core&format=json

Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex

4 December 2019

cites work

1 reference

12 December 2020

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

1 reference

12 December 2020

Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice.

1 reference

12 December 2020

Recombinant bacille Calmette-Guérin priming against measles

1 reference

12 December 2020

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice

1 reference

12 December 2020

Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae

1 reference

12 December 2020

Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.

1 reference

12 December 2020

Vaccination against tuberculosis by DNA injection

1 reference

12 December 2020

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

12 December 2020

A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae

1 reference

12 December 2020

Adjuvant modulation of immune responses to tuberculosis subunit vaccines.

1 reference

12 December 2020

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

12 December 2020

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

12 December 2020

Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein

1 reference

12 December 2020

Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis

1 reference

12 December 2020

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

12 December 2020

Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine

1 reference

12 December 2020

Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.

1 reference

12 December 2020

Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein

1 reference

12 December 2020

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

12 December 2020

Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guérin (BCG)

1 reference

12 December 2020

Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells

1 reference

12 December 2020

DNA encoding a single mycobacterial antigen protects against leprosy infection

1 reference

12 December 2020

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

12 December 2020

Immunopathogenesis of Mycobacterium avium infection

1 reference

12 December 2020

BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics

1 reference

12 December 2020

Prophylactic effect in mice of BCG vaccination against nontuberculous mycobacterial infections

1 reference

12 December 2020

New use of BCG for recombinant vaccines

1 reference

12 December 2020

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

12 December 2020

Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy

1 reference

12 December 2020

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

1 reference

12 December 2020

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

12 December 2020

Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.

1 reference

12 December 2020

Recombinant BCG as an antigen delivery system

1 reference

12 December 2020

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

1 reference

12 December 2020

Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon

1 reference

12 December 2020